Mark

Lebwohl

,

MD

Dean for Clinical Therapeutics, Professor and Chairman of Dermatology

Icahn School of Medicine at Mount Sinai

New York

United States

Councilor Since: January 1, 2007

IPC Councilor

Dr. Mark Lebwohl is the dean for clinical therapeutics, professor, and chairman emeritus of the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York. He graduated summa cum laude from Columbia College and earned his medical degree from Harvard Medical School.

Dr. Lebwohl served as President of the American Academy of Dermatology (AAD) from 2015–2016 and is past Chair of the AAD Psoriasis Task Force. He has directed numerous AAD symposia, including the annual Psoriasis Symposium, and served in leadership roles for both the AAD Annual and Summer Meetings. He is also Chairman Emeritus of the Medical Board of the National Psoriasis Foundation. Dr. Lebwohl is the founding editor of Psoriasis Forum (now The Journal of Psoriasis and Psoriatic Arthritis) and SKIN: The Journal of Cutaneous Medicine. He has served on the editorial boards of several leading dermatology journals, including the Journal of the American Academy of Dermatology (JAAD) and The Journal of Skin Cancer. He was the Dermatology Section Editor for Scientific American Medicine. He is the author or editor of several textbooks, including Treatment of Skin Disease, now in its sixth edition and translated into multiple languages.

An active clinical investigator, Dr. Lebwohl has participated in numerous trials for emerging dermatologic therapies and has authored or co-authored more than 800 publications. He is the recipient of numerous honors, including the National Psoriasis Foundation’s (NPF) first Lifetime Achievement Award, the AAD’s Gold Medal, and the American Skin Association’s Lifetime Achievement Award. In 2023, Newsweek recognized Dr. Lebwohl as the top medical dermatologist in the United States.

Last Updated:

07/10/2025

Areas of Interest

Clinical research.

IPC Committees / Groups

Diverse Skin Types Working Group

Languages Spoken

English

Involvement with Other Organization(s)

Past chairman and current member of the National Psoriasis Foundation (NPF) medical board.

Featured

Blog

IPC Symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting: Disease Interception, Treatment…

Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering…

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic…

What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis…

2025 IPC Think Tank Congress Report: Psoriasis, Metabolic Health, and GLP-1 Therapies.

The 2025 IPC Think Tank Congress Report highlights psoriasis as a systemic immunometabolic disease, linking obesity,…

Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council…

The International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…

View Report

Blog

Focus on Psoriasis: Highlights from the 2025 ESDR Annual Meeting.

The 2025 ESDR Congress in Antwerp brought together over 1,000 dermatology researchers. This report summarizes the…

Focus on Psoriasis: Highlights from the 2025 EADV Congress.

At the 2025 EADV Annual Meeting in Paris, experts shared new insights into psoriasis diagnosis, symptoms, and…

Advancing Biosimilars and Optimizing Psoriasis Treatment: Highlights from the 2025 ICD Symposium.

Experts from across five continents discuss regional biosimilar uptake and practical strategies for optimizing…

Focus on Psoriasis: Highlights from the 2025 Society for Investigative Dermatology (SID) Annual Meeting.

IPC’s 2025 SID Congress Report highlights the most impactful psoriasis sessions, covering novel cell-biology…

Highlights from the 2025 American Academy of Dermatology (AAD) Annual Meeting: Psoriasis Comorbidities, New Treatments,…

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

A Report from the 2025 American Academy of Dermatology (AAD) Annual Meeting.

The 2025 AAD Annual Meeting featured important updates on psoriasis therapies, comorbidities, and late-breaking…

View Report

PDF

Psoriasis in People With Skin of Color: An Evidence-Based Update.

This article provides an evidence-based update on psoriasis in individuals with skin of color (SOC), highlighting…

View Report

Blog

Focus on Psoriasis: A Report from the Psoriasis: From Gene to Clinic 10th International Congress.

The Psoriasis: From Gene to Clinic Congress Report highlights breakthroughs in genetics, clinical care, and treatment…

Psoriasis in Older Patients: Key Considerations and Best Practices for Effective Management.

Psoriasis in older patients presents unique challenges. This article discusses treatment considerations, risks of side…

Focus on Psoriasis: A Report from the 2024 American Academy of Dermatology (AAD) Annual Meeting.

The 2024 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 7 – Tuesday, March 12, 2024,…

Focus on Psoriasis: A Report from the 2022 American Academy of Dermatology (AAD) Annual Meeting.

The 2022 American Academy of Dermatology (AAD) Annual Meeting was held Thursday, March 24 – Tuesday, March 29 in…

Focus on Psoriasis - A Report from the 2022 American Academy of Dermatology (AAD) Annual Meeting.

View Report

PDF

Focus on Psoriasis – A Report from the 2021 Hybrid Gene to Clinic Congress.

View Report

Blog

Mark Lebwohl COVID-19.

Commentary from IPC Councilor Mark Lebwohl, MD, on a case series in NEJM on COVID-19 in immune-mediated inflammatory…

Long-term Management of Scalp Psoriasis: Perspectives from the International Psoriasis Council.

View Report

Load More Show Less

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What's New

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.

Friday, September 25, 2026

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Advancing Knowledge. Improving Care.

Mark

Lebwohl

,

MD

Areas of Interest

IPC Committees / Groups

Languages Spoken

Involvement with Other Organization(s)

Quick Links

Follow us

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

Wednesday, September 9, 2026